Publication | Closed Access

High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany

Hematological MalignancyOncologyMalignant Blood DisorderHematologyOutcomes ResearchMultiple MyelomaPharmacotherapyHigh AdherenceImmunomodulatory DrugsMedicineRadiation OncologyHealth Sciences